Dopexamine increases internal mammary artery blood flow following coronary artery bypass grafting.
AuthorsFlynn, Michael J
Winter, Desmond C
AffiliationDepartment of Cardiothoracic Surgery, Cork University Hospital, Wilton, Cork,, Ireland. email@example.com
*Coronary Artery Bypass
Coronary Circulation/*drug effects
Dopamine/*analogs & derivatives/*pharmacology
Mammary Arteries/*drug effects/physiopathology/transplantation
MetadataShow full item record
CitationEur J Cardiothorac Surg. 2003 Oct;24(4):547-51.
JournalEuropean journal of cardio-thoracic surgery : official journal of the European, Association for Cardio-thoracic Surgery
AbstractOBJECTIVE: Vasoactive agents and inotropes influence conduit-coronary blood flow following coronary artery bypass grafting (CABG). It was hypothesized that dopexamine hydrochloride, a dopamine A-1 (DA-1) and beta(2) agonist would increase conduit-coronary blood flow. A prospective randomized double blind clinical trial was carried out to test this hypothesis. DA-1 receptors have previously been localized to human left ventricle. METHODS: Twenty-six American Society of Anaesthesiology class 2-3 elective coronary artery bypass graft patients who did not require inotropic support on separation from cardiopulmonary bypass (CPB) were studied. According to a randomized allocation patients received either dopexamine (1 microg/kg per min) or placebo (saline) by intravenous infusion for 15 min. Immediately prior to and at 5,10 and 15 min of infusion, blood flow through the internal mammary and vein grafts (Transit time flow probes, Transonic Ltd.), heart rate, cardiac index, mean arterial pressure and pulmonary haemodynamics were noted. The data were analysed using multivariate analysis of variance. RESULTS: Low-dose dopexamine (1 microg/kg per min) caused a significant increase in mammary graft blood flow compared to placebo at 15 min of infusion (P=0.028, dopexamine group left internal mammary artery (LIMA) flow of 43.3+/-14.2 ml/min, placebo group LIMA flow at 26.1+/-16.3 ml/min). Dopexamine recipients demonstrated a non-significant trend to increased saphenous vein graft flow (P=0.059). Increased heart rate was the only haemodynamic change induced by dopexamine (P=0.004, dopexamine group at 85.2+/-9.6 beats/min and placebo group at 71.1+/-7.6 beats/min after 15 min of infusion). CONCLUSION: This study demonstrates that administration of dopexamine (1 microg/kg per min) was associated with a significant increase in internal mammary artery graft blood flow with mild increase in heart rate being the only haemodynamic change. Low-dose dopexamine may improve graft flow in the early post CABG period with minimal haemodynamic changes.
- The effect of fenoldopam and dopexamine on hepatic blood flow and hepatic function following coronary artery bypass grafting with hypothermic cardiopulmonary bypass.
- Authors: Adluri RK, Singh AV, Skoyles J, Robins A, Hitch A, Baker M, Mitchell IM
- Issue date: 2009 Jun
- Prostaglandin E1 increases the blood flow rate of saphenous vein grafts in patients undergoing off-pump coronary artery bypass grafting.
- Authors: Zhao L, Lu J, Wang C, Zhao W, Qing E, Ma J
- Issue date: 2013 Dec
- Hemodynamic and renal effects of dopexamine and dobutamine in patients with reduced cardiac output following coronary artery bypass grafting.
- Authors: MacGregor DA, Butterworth JF 4th, Zaloga CP, Prielipp RC, James R, Royster RL
- Issue date: 1994 Sep
- Enhancing liver blood flow after cardiopulmonary bypass: the effects of dopamine and dopexamine.
- Authors: Sharpe DA, Mitchel IM, Kay EA, McGoldrick JP, Munsch CM, Kay PH
- Issue date: 1999 Jan
- The effects of fenoldopam on coronary conduit blood flow after coronary artery bypass graft surgery.
- Authors: Halpenny M, Lakshmi S, O'Donnell A, O'Callaghan-Enright S, O'Connell D, Shorten G
- Issue date: 2001 Feb